News
Team Trump canceled a $770 mln contract with Moderna to develop an H5 vaccine. In a cost-benefit analysis, it’s a dangerous ...
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
Over the past three years, avian influenza (H5N1) has spread around the U.S. and affected many species of birds and mammals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback